We prospectively evaluated the relationship between circulating fatty acids and breast cancer risk in what is, to our knowledge, the first study to leverage tumor tissue to assess heterogeneity by expression levels of immuno-inflammatory markers and FAS. This evidence concerns the gene FAS and neoplasm.